PubPeer
The online Journal club
login
create account
Home
Publications
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
BMC Infectious Diseases (2020) -
Comments
doi: 10.1186/s12879-020-05507-4 issn: 1471-2334 pubmed: 33087047
Naser Gharebaghi, Rahim Nejadrahim, Seyed Jalil Mousavi, Seyyed-Reza Sadat-Ebrahimi, Reza Hajizadeh
Go to article
Go to preprint
Springer Science and Business Media LLC
Comments awaiting moderation ({{totalComments}})
Review last reports ({{totalReports}})
Review last email suggestions ({{totalPendingEmails}})
Last month's whitelisted comments ({{totalWhitelistedComments}})